Compare BioNTech SE - ADR (BNTX) vs Cintas Corporation (CTAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Cintas Corporation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Cintas Corporation trades at $205.28 (market cap $82.15B). The key difference: Cintas Corporation is far larger — about 3.5× BioNTech SE - ADR's market cap, and Cintas Corporation pays a 1.01% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | CTAS | |
|---|---|---|
Market Cap | $23.31B | $82.15B |
Sector | Health | Industrials |
52-Week High | $119.34 | $225.10 |
52-Week Low | $83.89 | $163.55 |
Enterprise Value | $6.60B | $84.56B |
Dividend Yield | — | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →
